FDA Inspection 1019795 — SmithKline Beecham Pharma GmbH & co. KG

SmithKline Beecham Pharma GmbH & co. KG — FEI 3004835618

The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on June 27, 2017 in Dresden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 27, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)